A practical checklist for return of results from genomic research in the European context.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 12 09 2022
accepted: 21 02 2023
revised: 13 02 2023
medline: 12 6 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: ppublish

Résumé

An increasing number of European research projects return, or plan to return, individual genomic research results (IRR) to participants. While data access is a data subject's right under the General Data Protection Regulation (GDPR), and many legal and ethical guidelines allow or require participants to receive personal data generated in research, the practice of returning results is not straightforward and raises several practical and ethical issues. Existing guidelines focusing on return of IRR are mostly project-specific, only discuss which results to return, or were developed outside Europe. To address this gap, we analysed existing normative documents identified online using inductive content analysis. We used this analysis to develop a checklist of steps to assist European researchers considering whether to return IRR to participants. We then sought feedback on the checklist from an interdisciplinary panel of European experts (clinicians, clinical researchers, population-based researchers, biobank managers, ethicists, lawyers and policy makers) to refine the checklist. The checklist outlines seven major components researchers should consider when determining whether, and how, to return results to adult research participants: 1) Decide which results to return; 2) Develop a plan for return of results; 3) Obtain participant informed consent; 4) Collect and analyse data; 5) Confirm results; 6) Disclose research results; 7) Follow-up and monitor. Our checklist provides a clear outline of the steps European researchers can follow to develop ethical and sustainable result return pathways within their own research projects. Further legal analysis is required to ensure this checklist complies with relevant domestic laws.

Identifiants

pubmed: 36949262
doi: 10.1038/s41431-023-01328-6
pii: 10.1038/s41431-023-01328-6
pmc: PMC10250331
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

687-695

Subventions

Organisme : Wellcome Trust
ID : 203132
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203132
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203132
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

J Med Ethics. 2021 Oct;47(10):689-696
pubmed: 33441306
J Med Ethics. 2015 Apr;41(4):317-21
pubmed: 25038088
Circ Genom Precis Med. 2022 Apr;15(2):e003459
pubmed: 35130028
Genet Med. 2012 Apr;14(4):411-6
pubmed: 22382800
Genet Med. 2019 Feb;21(2):311-318
pubmed: 29904163
Front Public Health. 2021 Jul 01;9:697381
pubmed: 34277554
Genet Med. 2017 Mar;19(3):283-293
pubmed: 27584911
J Med Ethics. 2018 Jun;44(6):397-403
pubmed: 29496751
Front Genet. 2021 Oct 29;12:763159
pubmed: 34777479
Am J Epidemiol. 2014 Sep 15;180(6):562-4
pubmed: 25150271
Genet Med. 2020 Feb;22(2):345-352
pubmed: 31477844
Eur J Hum Genet. 2020 Dec;28(12):1656-1661
pubmed: 32523053
Eur J Hum Genet. 2021 Mar;29(3):471-481
pubmed: 33230308
J Pers Med. 2020 May 13;10(2):
pubmed: 32413979
Eur J Hum Genet. 2021 Mar;29(3):365-377
pubmed: 33223530
New Genet Soc. 2017 Sep 06;36(4):336-353
pubmed: 29238265
Eur J Hum Genet. 2016 Jan;24(1):21-9
pubmed: 25920556
Eur J Hum Genet. 2012 Mar;20(3):258-62
pubmed: 22126749
PLoS One. 2021 Nov 8;16(11):e0258646
pubmed: 34748551
BMC Med Genomics. 2019 Nov 27;12(1):173
pubmed: 31775751
Genome Med. 2021 Jul 15;13(1):115
pubmed: 34266500
Genet Med. 2020 Oct;22(10):1667-1672
pubmed: 32555418
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Am J Hum Genet. 2018 Sep 6;103(3):328-337
pubmed: 30100086
J Pers Med. 2018 Jan 03;8(1):
pubmed: 29301385
Eur J Hum Genet. 2021 Feb;29(2):231-240
pubmed: 33011736
Eur J Hum Genet. 2006 Nov;14(11):1170-8
pubmed: 16868560
Sci Rep. 2019 Jul 29;9(1):10964
pubmed: 31358886
Biopreserv Biobank. 2016 Jun;14(3):241-8
pubmed: 27082461
Am J Hum Genet. 2021 Dec 2;108(12):2224-2237
pubmed: 34752750
J Law Med Ethics. 2014 Fall;42(3):344-55
pubmed: 25264092
Eur J Hum Genet. 2018 Jan;26(1):36-43
pubmed: 29184171
Eur J Hum Genet. 2022 Mar;30(3):363-366
pubmed: 34602610
Am J Med Genet B Neuropsychiatr Genet. 2019 Dec;180(8):589-600
pubmed: 30358063
Eur J Hum Genet. 2019 Apr;27(4):535-546
pubmed: 30622328
Genet Med. 2021 Aug;23(8):1582-1584
pubmed: 34345026
Eur J Hum Genet. 2013 Jun;21(6):580-4
pubmed: 23676617
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669

Auteurs

Danya F Vears (DF)

Biomedical Ethics Research Group, Murdoch Children's Research Institute, Parkville, VIC, 3052, Australia. danya.vears@mcri.edu.au.
University of Melbourne, Parkville, VIC, 3052, Australia. danya.vears@mcri.edu.au.
Centre for Biomedical Ethics and Law, KU Leuven, Leuven, 3000, Belgium. danya.vears@mcri.edu.au.
Uehiro Centre for Practical Ethics, University of Oxford, Oxford, OX3 7RF, UK. danya.vears@mcri.edu.au.

Nina Hallowell (N)

Ethox Centre and Wellcome Centre for Ethics and Humanities, Nuffield department of Population Health, University of Oxford, Oxford, OX3 7RF, UK.

Heidi Beate Bentzen (HB)

Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo, Norway.

Bridget Ellul (B)

Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.

Therese Haugdahl Nøst (TH)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, N-9037, Tromsø, Norway.
K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health, NTNU, Norwegian University of Science and Technology, N- 7491, Trondheim, Norway.

Angeliki Kerasidou (A)

Ethox Centre and Wellcome Centre for Ethics and Humanities, Nuffield department of Population Health, University of Oxford, Oxford, OX3 7RF, UK.

Shona M Kerr (SM)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK.

Michaela Th Mayrhofer (M)

BBMRI-ERIC, Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.

Signe Mežinska (S)

Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.

Elizabeth Ormondroyd (E)

Radcliffe Department of Medicine, NIHR Oxford Biomedical Research Centre United Kingdom, University of Oxford, Oxford, UK.

Berge Solberg (B)

Department of Public Health and Nursing, The Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Birgitte Wirum Sand (BW)

Norwegian Institute of Public Health, Legal department, Oslo, Norway.

Isabelle Budin-Ljøsne (I)

Division of Climate and Environmental Health, Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH